FindTrial
Sign In

The role of androgen levels in the occurrence and development of stress urinary incontinence in postmenopausal women: a prospective cohort study using intelligent follow-up software

The role of androgen levels in the occurrence and development of stress urinary incontinence in postmenopausal women: a prospective cohort study using intelligent follow-up software

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500107024
Enrollment
Unknown
Registered
2025-08-01
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress urinary incontinence

Interventions

trial group:Androgen levels

Sponsors

Gongli Hospital of Shanghai Pudong New Area
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Postmenopausal women aged between 50-70 years old; 2.No SUI symptoms and no relevant treatment received; 3.Capable of using smartphones or other electronic devices, willing to use intelligent follow-up software. 4.Voluntarily participate in this study and sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Individuals previously diagnosed with SUI or other types of urinary incontinence; 2.Individuals with severe heart, liver, kidney dysfunction or other serious illnesses; 3.Those who are unable to use smart devices or unwilling to use follow-up software;

Design outcomes

Primary

MeasureTime frame
Androgen and estrogen levels;—

Secondary

MeasureTime frame
Ingelman Sundberg rating;—

Countries

China

Contacts

Public ContactLv Jianwei

Shanghai Pudong New Area Gongli Hospital

ljwass@126.com+86 21 55858730

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026